- Nachrichtendetail
-
12.03.2024 11:02:26 - dpa-AFX: *IDEAYA BIOSCIENCES ENTERS CLINICAL TRIAL COLLABORATION WITH MERCK TO EVALUATE IDE161 WITH KEYTRUDA IN ENDOMETRIAL CANCER
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 130,485 | 10.05.24 20:54:23 | +0,255 | +0,20% | 130,480 | 130,490 | 130,820 | 130,230 |
